We hope that this list of publications on cannabinoids and their potential uses with regard to their pharmacological effects can help you to understand the real potential of CBD. iAmHealth is constantly striving to keep the knowledge and information about them up to date and we will at the same time inform on this platform about the most important discoveries concerning various therapeutic and other applications. In the following subsections you will find an up-to-date list with links to the most important scientific studies on cannabinoids in medicine, arranged by specific diseases.
Translated with www.DeepL.com/Translator (free version)
Robust clinical studies are still needed to assess the full potential of cannabinoids under controlled conditions. However, preclinical studies already suggest that CBD has a broad spectrum of effects and properties that may be therapeutically useful. CBD is a component of the pharmacologically used hemp extract nabiximol, which is used as an antispasmodic in multiple sclerosis. For this indication it is available as a mouth spray since 2011. In addition, it has been on the market since October 2019 for the treatment of rare forms of epilepsy: it is approved for the oral treatment of certain forms of childhood epilepsy (Lennox-Gastaut syndrome, Dravet syndrome).
Currently, more than 160 clinical studies are being conducted worldwide. You can find more information about a specific study directly on the official website.